Clinical trial
Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance: Prospective, Randomized, Open, Blinded Outcome Evaluation, and Feasibility Trial
NCT03024476 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance: Prospective, Randomized, Open, Blinded Outcome Evaluation, and Feasibility Trial
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 1, 2016
- Completion date
- December 7, 2017
- Enrollment
- 67 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.